Skip to main content
Top
Published in: Breast Cancer 4/2020

01-07-2020 | Breast Cancer | Original Article

Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey

Authors: Yuka Goto, Koichiro Tsugawa, Yuko Furuya, Miwako Maezato, Yoshimi Tagami, Yuri Ogawa, Misako Saisu, Memi Yamazaki, Fuyumi Kuramochi

Published in: Breast Cancer | Issue 4/2020

Login to get access

Abstract

Background

The US Preventative Services Task Force assessed the efficacy of breast cancer screening according to the sum of its benefits and disadvantages. We estimate that the balance of the benefits and disadvantages varies among women depending on their demographic background.

Methods

Between March 2016 and March 2017, we conducted a questionnaire survey among Japanese women who underwent population-based or opportunistic breast cancer screening at our multicenter institutions. We investigated the behavior modification among women after being informed about the benefits and disadvantages of breast cancer screening depending on their demographic background.

Results

Out of 3032 questionnaires that were returned, 2936 (96.8%) were evaluated. The percentage of women with prior knowledge about the benefits and disadvantages of breast cancer screening before reading the leaflets that we created was 24%. However, 95% of the women were willing to undergo screening next time, despite knowing the disadvantages. Regarding overdiagnosis, the young women tended to choose usual treatment, and the elderly women tended to choose active surveillance. In response to the question on the significance of screening, the young women wished to avoid death by breast cancer; whereas, the elderly women wished to live a safe life.

Conclusion

Our results indicate that the information of disadvantages does not lead to a reduction in screening rates. Additionally, we found that the balance between the benefits and disadvantages of breast cancer screening varies among women depending on their demographic background, especially age.
Literature
1.
go back to reference US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716–26.CrossRef US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716–26.CrossRef
2.
go back to reference Japanese Breast Cancer Society. Breast cancer treatment guideline for patients 2015. Tokyo: Kanehara Shoten; 2015 (in Japanese). Japanese Breast Cancer Society. Breast cancer treatment guideline for patients 2015. Tokyo: Kanehara Shoten; 2015 (in Japanese).
3.
go back to reference Ohuchi N, Ishida Y, Kawai M, Narikawa Y, Yamamoto S, Sobue T. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40–49 (J-START): research design. Jpn J Clin Oncol. 2010;41:275–7.CrossRef Ohuchi N, Ishida Y, Kawai M, Narikawa Y, Yamamoto S, Sobue T. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40–49 (J-START): research design. Jpn J Clin Oncol. 2010;41:275–7.CrossRef
4.
go back to reference Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366.CrossRef Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366.CrossRef
5.
go back to reference Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.CrossRef Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.CrossRef
6.
go back to reference De Gelder R, Heijnsdijk EAM, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011;33:111–21.CrossRef De Gelder R, Heijnsdijk EAM, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011;33:111–21.CrossRef
7.
go back to reference Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer. 2009;45:3166–71.CrossRef Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer. 2009;45:3166–71.CrossRef
8.
go back to reference Junod B, Zahl P-H, Kaplan RM, Olsen J, Greenland S. An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer. 2011;11:401.CrossRef Junod B, Zahl P-H, Kaplan RM, Olsen J, Greenland S. An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer. 2011;11:401.CrossRef
9.
go back to reference Zahl P-H, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004;328:921–4.CrossRef Zahl P-H, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004;328:921–4.CrossRef
10.
go back to reference Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013;11:106–15.CrossRef Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013;11:106–15.CrossRef
11.
go back to reference Baum M. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ. 2013;346:f385.CrossRef Baum M. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ. 2013;346:f385.CrossRef
13.
go back to reference Thornton H. Pairing accountability with responsibility: the consequences of screening ‘promotion’. Med Sci Monit. 2001;7:531–3.PubMed Thornton H. Pairing accountability with responsibility: the consequences of screening ‘promotion’. Med Sci Monit. 2001;7:531–3.PubMed
14.
go back to reference Hersch J, Barratt A, Jansen J, Houssami N, Irwig L, Jacklyn G, et al. The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial. BMJ Open. 2014;4:e004990.CrossRef Hersch J, Barratt A, Jansen J, Houssami N, Irwig L, Jacklyn G, et al. The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial. BMJ Open. 2014;4:e004990.CrossRef
15.
go back to reference Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.CrossRef Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.CrossRef
16.
go back to reference Waller J, Douglas E, Whitaker KL, Wardle J. Women’s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open. 2013;3:e002703.CrossRef Waller J, Douglas E, Whitaker KL, Wardle J. Women’s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open. 2013;3:e002703.CrossRef
18.
go back to reference Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asia and Western countries? World J Surg. 2010;34:2308–24.CrossRef Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asia and Western countries? World J Surg. 2010;34:2308–24.CrossRef
19.
go back to reference Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. AJR. 2003;181:177–82.CrossRef Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. AJR. 2003;181:177–82.CrossRef
21.
go back to reference Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205–40.CrossRef Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205–40.CrossRef
22.
go back to reference Etzioni R, Gulati R, Mallinger L, Mondelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med. 2013;158:831–8.CrossRef Etzioni R, Gulati R, Mallinger L, Mondelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med. 2013;158:831–8.CrossRef
23.
go back to reference Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women’s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320:1635–40.CrossRef Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women’s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320:1635–40.CrossRef
24.
go back to reference Gummersbach E, in der Schmitten J, Mortsiefer A, Abholz HH, Wegscheider K, Pentzek M. Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content. Dtsch Arztebl Int. 2015;112:61–8.PubMedPubMedCentral Gummersbach E, in der Schmitten J, Mortsiefer A, Abholz HH, Wegscheider K, Pentzek M. Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content. Dtsch Arztebl Int. 2015;112:61–8.PubMedPubMedCentral
25.
go back to reference Takayoshi U. The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan. Breast Cancer. 2017;24(1):26–31.CrossRef Takayoshi U. The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan. Breast Cancer. 2017;24(1):26–31.CrossRef
Metadata
Title
Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey
Authors
Yuka Goto
Koichiro Tsugawa
Yuko Furuya
Miwako Maezato
Yoshimi Tagami
Yuri Ogawa
Misako Saisu
Memi Yamazaki
Fuyumi Kuramochi
Publication date
01-07-2020
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2020
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-020-01071-6

Other articles of this Issue 4/2020

Breast Cancer 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine